Neurim Pharmaceuticals (1991) Ltd & Anor v Generics UK Ltd (t/a Mylan) & Anor [2020] EWCA Civ 793

Court of Appeal (Civil Division) · 2020-06-24 · Intellectual Property · cited by 2 · influence score 14/100 Appeal Dismissed

Is it still good law? No negative treatment found in this dataset — it has been cited without being doubted or overruled here.

How to cite

Neutral citation format (OSCOLA). Always confirm against the official judgment.

Treatment

Cited · 2

Cited — Neurim Pharmaceuticals (1991) Limited & Anor. v Generics (UK) Limited & Anor. 2022-03-29
“…ringement prior to the expedited trial and (b) there was no evidence that any other generic supplier was likely to come on the market during that interval: see [2020] EWCA Civ 793 at [43]-[55] (Floyd LJ).…”
Cited — Neurim Pharmaceuticals (1991) Limited & Anor. v Generics (UK) Limited & Anor. 2022-03-29
“…ringement prior to the expedited trial and (b) there was no evidence that any other generic supplier was likely to come on the market during that interval: see [2020] EWCA Civ 793 at [43]-[55] (Floyd LJ).…”